These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2078973)

  • 1. Impaired oxidative metabolism of salicylate in Reye's syndrome.
    Meert KL; Kauffman RE; Deshmukh DR; Sarnaik AP
    Dev Pharmacol Ther; 1990; 15(2):57-60. PubMed ID: 2078973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reye's syndrome. Salicylate metabolism, viral antibody levels, and other factors in surviving patients and unaffected family members.
    Chu AB; Nerurkar LS; Witzel N; Andresen BD; Alexander M; Kang ES; Brouwers P; Fedio P; Lee YJ; Sever JL
    Am J Dis Child; 1986 Oct; 140(10):1009-12. PubMed ID: 3019125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salicylate and mitochondrial monoamine oxidase function in Reye's syndrome.
    Faraj BA; Caplan D; Lolies P; Buchanan C
    J Pharm Sci; 1987 Jun; 76(6):423-6. PubMed ID: 3625483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum salicylate concentrations in Reye's disease. A study of 130 biopsy-proven cases.
    Partin JS; Partin JC; Schubert WK; Hammond JG
    Lancet; 1982 Jan; 1(8265):191-4. PubMed ID: 6119559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ammonium chloride inhibits pyruvate oxidation in rat liver mitochondria: a possible cause of fatty liver in Reye's syndrome and urea cycle defects.
    Maddaiah VT; Kumbar U
    Clin Sci (Lond); 1994 Nov; 87(5):499-503. PubMed ID: 7874836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reye's syndrome in a child on long-term salicylate medication.
    Christoffersen P; Faarup P; Geertinger P; Krogh P
    Forensic Sci Int; 1980; 15(2):129-33. PubMed ID: 7358324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reye's syndrome: salicylates and mitochondrial functions.
    Martens ME; Lee CP
    Biochem Pharmacol; 1984 Sep; 33(18):2869-76. PubMed ID: 6477646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of subchronic parathion administration on sodium salicylate excretion kinetics in female rats.
    Martínez Tabche L; Posadas del Rio FA
    J Appl Toxicol; 1989 Feb; 9(1):5-8. PubMed ID: 2926096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct analysis of salicylic acid, salicyl acyl glucuronide, salicyluric acid and gentisic acid in human plasma and urine by high-performance liquid chromatography.
    Liu JH; Smith PC
    J Chromatogr B Biomed Appl; 1996 Jan; 675(1):61-70. PubMed ID: 8634769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of liver ultrastructure in salicylate intoxication and Reye's syndrome.
    Partin JS; Daugherty CC; McAdams AJ; Partin JC; Schubert WK
    Hepatology; 1984; 4(4):687-90. PubMed ID: 6745858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of inhibition of beta-oxidation by aspirin metabolites in skin fibroblasts from Reye's syndrome patients and controls.
    Glasgow JF; Middleton B; Moore R; Gray A; Hill J
    Biochim Biophys Acta; 1999 May; 1454(1):115-25. PubMed ID: 10354521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability of salicylate from salsalate and aspirin.
    Dromgoole SH; Cassell S; Furst DE; Paulus HE
    Clin Pharmacol Ther; 1983 Oct; 34(4):539-45. PubMed ID: 6617077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of salicylic acid and its metabolites in urine by derivative synchronous spectrofluorimetry.
    Salinas F; Muñoz de la Peña A; Durán-Merás I; Soledad Durán M
    Analyst; 1990 Jul; 115(7):1007-11. PubMed ID: 2221396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.
    Osterloh J; Cunningham W; Dixon A; Combest D
    Med Toxicol Adverse Drug Exp; 1989; 4(4):272-94. PubMed ID: 2671597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public Health Service study of Reye's syndrome and medications. Report of the main study.
    Hurwitz ES; Barrett MJ; Bregman D; Gunn WJ; Pinsky P; Schonberger LB; Drage JS; Kaslow RA; Burlington DB; Quinnan GV
    JAMA; 1987 Apr; 257(14):1905-11. PubMed ID: 3820509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation of serum salicylate levels in Reye's syndrome: a comparison between the Natelson colorimetric method and high performance liquid chromatography.
    Clark JH; Nagamori K; Fitzgerald JF
    Clin Chim Acta; 1985 Feb; 145(3):243-7. PubMed ID: 3987027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reye's syndrome and salicylate use.
    Starko KM; Ray CG; Dominguez LB; Stromberg WL; Woodall DF
    Pediatrics; 1980 Dec; 66(6):859-64. PubMed ID: 7454476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salicylate and mitochondrial injury in Reye's syndrome.
    You K
    Science; 1983 Jul; 221(4606):163-5. PubMed ID: 6857275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome.
    Trost LC; Lemasters JJ
    Toxicol Appl Pharmacol; 1997 Dec; 147(2):431-41. PubMed ID: 9439738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reye's syndrome--a severe complication of salicylate therapy].
    Vengerovskiĭ AI; Baturina NO; Saratikov AS
    Eksp Klin Farmakol; 2000; 63(2):76-80. PubMed ID: 10834102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.